ArticleCommunications biology2021

A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.

Ying Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.